LaboratoryCorporation

Yangiliklar

Reuters - 4 kun oldin

Praia Health Secures Strategic Investment From Labcorp Venture Fund, Announces New Collaboration To Streamline Patient Lab Ordering Experience

BRIEF-Praia Health Secures Strategic Investment From Labcorp Venture Fund, Announces New Collaboration To Streamline Patient Lab Ordering Experience Nov 4 (Reuters) - Labcorp Holdings Inc LH.N : PRAIA HEALTH SECURES STRATEGIC INVESTMENT FROM LABCORP VENTURE FUND, ANNOUNCES NEW COLLABORATION TO STREAMLINE PATIENT LAB ORDERING EXPERIENCE Source text:

Reuters - 2 hafta oldin

U.S. STOCKS Newmont, Monopar Therapeutics, TKO Group

BUZZ-U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The Nasdaq jumped on Thursday, driven by Tesla's positive earnings forecast, which buoyed market sentiment despite declines from other corporate results and pressure from rising Treasury yields.

Reuters - 2 hafta oldin

Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary

Labcorp Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary Labcorp Holdings Inc LH.N reported quarterly adjusted earnings of $3.50 per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $3.38. The mean expectation of seventeen analysts for the quarter was for earnings of $3.48 per share.

Reuters - 2 hafta oldin

U.S. STOCKS Teck Resources, Nasdaq, T-Mobile

BUZZ-U.S. STOCKS ON THE MOVE-Teck Resources, Nasdaq, T-Mobile Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq rebounded on Thursday, after Tesla's upbeat earnings forecast lifted market sentiment following a selloff in the previous session, kicking off megacap results on a promising note.

Reuters - 2 hafta oldin

Labcorp's quarterly results beat on diagnostic tests demand

UPDATE 1-Labcorp's quarterly results beat on diagnostic tests demand Adds analyst comment in paragraphs 5-6, changes story keyword used by media customers to LABCORP HLDG-RESULTS/ Oct 24 (Reuters) - Laboratory operator Labcorp LH.N beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from hurricane-led disruptions.

Reuters - 2 hafta oldin

Labcorp beats quarterly estimates on diagnostic test demand

Labcorp beats quarterly estimates on diagnostic test demand Oct 24 (Reuters) - Laboratory operator Labcorp LH.N on Thursday beat Wall Street estimates for third-quarter profit and revenue, helped by demand for diagnostic tests. Diagnostic checkups have risen in recent quarters as more people, especially older adults, caught up on surgeries deferred during the pandemic.

Reuters - 2 hafta oldin

US lab operator Quest Diagnostics to launch bird flu test at end of October

US lab operator Quest Diagnostics to launch bird flu test at end of October Oct 23 - Lab operator Quest Diagnostics DGX.N said on Wednesday it will launch a test for H5N1 bird flu at the end of October after the U.S. Centers for Disease Control and Prevention (CDC) gave it contracts to support testing for two emerging infectious diseases, including the Oropouche virus.

Reuters - 2 hafta oldin

Labcorp Holdings Inc <LH.N> expected to post earnings of $3.49 a share - Earnings Preview

Labcorp Holdings Inc expected to post earnings of $3.49 a share - Earnings Preview Labcorp Holdings Inc LH.N , LH is expected to show a rise in quarterly revenue when it reports results on October 24 for the period ending September 30 2024 The Burlington North Carolina-based company is expected to report a 6.6% increase in revenue to $3.26 billion from $3.06 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.

Reuters - 3 hafta oldin

NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only Marketing Authorized Over-The-Counter Syphilis Test In The U.S.

BRIEF-NOWDiagnostics And Labcorp Collaborate To Expand Access To The Only FDA-Marketing Authorized Over-The-Counter Syphilis Test In The U.S. Oct 16 (Reuters) - Labcorp Holdings Inc LH.N : NOWDIAGNOSTICS AND LABCORP COLLABORATE TO EXPAND ACCESS TO THE ONLY FDA-MARKETING AUTHORIZED OVER-THE-COUNTER SYPHILIS TEST IN THE U.S. Source text for Eikon: ID

Reuters - 4 hafta oldin

Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test

BRIEF-Labcorp Expands Sexually Transmitted Infection Test Offerings With Rapid Syphilis Test Oct 10 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP EXPANDS SEXUALLY TRANSMITTED INFECTION (STI) TEST OFFERINGS WITH RAPID SYPHILIS TEST LABCORP: PLANS TO MAKE TEST AVAILABLE TO PROVIDERS BY END OF 2024 AND DIRECTLY TO PATIENTS THROUGH LABCORP ONDEMAND I

Reuters - 1 oy oldin

WHO approves first mpox diagnostic test for emergency use

UPDATE 4-WHO approves first mpox diagnostic test for emergency use Updates Oct. 3 story to add company statement in paragraph 4 Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' ABT.N mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's effort to bolster testing capabilities in countries facing outbreaks of the disease.

Reuters - 1 oy oldin

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp

Reuters - 1 oy oldin

U.S. STOCKS IonQ, Cassava Sciences, MeridianLink

BUZZ-U.S. STOCKS ON THE MOVE-IonQ, Cassava Sciences, MeridianLink Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.

Reuters - 1 oy oldin

U.S. STOCKS Regeneron, HP Inc, Honeywell International

BUZZ-U.S. STOCKS ON THE MOVE-Regeneron, HP Inc, Honeywell International Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The blue-chip Dow rose on Friday to hit an intraday record high and small-cap stocks outperformed after a benign inflation report cleared the way for the Federal Reserve to focus on shoring up the labor market while continuing its interest rate easing.

Reuters - 1 oy oldin

Delay in reimbursement cut to ease pressure on U.S. lab operators, analysts say

BUZZ-Delay in reimbursement cut to ease pressure on U.S. lab operators, analysts say ** Delay in cuts to reimbursement rates for some lab tests under Medicare to aid 2025 rev and earnings of U.S. lab owners such as Labcorp LH.N and Quest Diagnostics DGX.N , analysts say ** LH shares rise 1.1% to $222.73, DGX shares up nearly 1% to $155.51 ** U.S. Congress on Wednesday deferred cuts to reimbursement rates from 2025 to 2026 ** "The delay was in-line with expectations as both LH and DGX have previo

Reuters - 2 oy oldin

U.S. Cardinal Health, Factset, Paylocity

U.S. RESEARCH ROUNDUP-Cardinal Health, Factset, Paylocity Sept 23 (Reuters) - .Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cardinal Health, Factset and Paylocity Holding on Monday. HIGHLIGHTS * Cardinal Health Inc CAH.N : Baird raises target price to $140 from $137 * Factset FDS.N : Jefferies raises target price to $486 from $435 * Marinus Pharmaceuticals Inc MRNS.O : Oppenheimer raises to outperform from perform * Paylocity

Reuters - 2 oy oldin

U.S. Factset, FedEx, Thermo Fisher Scientific

U.S. RESEARCH ROUNDUP-Factset, FedEx, Thermo Fisher Scientific Sept 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Factset, FedEx and Thermo Fisher Scientific on Friday. HIGHLIGHTS * Arthur J. Gallagher & Co. AJG.N : RBC raises target price to $320 from $310 * Factset FDS.N : RBC raises target price to $503 from $464 * FedEx Corp FDX.N : Baird cuts target price to $320 from $340 * IQVIA Holdings Inc IQV.N : Baird

Reuters - 2 oy oldin

Cinven To Sell Minority Stake In SYNLAB To Labcorp

BRIEF-Cinven To Sell Minority Stake In SYNLAB To Labcorp Sept 17 (Reuters) - Cinven: CINVEN: TO SELL MINORITY STAKE IN SYNLAB TO LABCORP CINVEN: PURCHASE PRICE FOR INDIRECT MINORITY STAKE OF 15% WAS ABOUT EUR 140 MILLION Further company coverage: LH.N

Reuters - 2 oy oldin

Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health

BRIEF-Labcorp Completes Acquisition Of Select Assets Of Bioreference Health's Diagnostics Business From Opko Health Sept 16 (Reuters) - Labcorp Holdings Inc LH.N : LABCORP COMPLETES ACQUISITION OF SELECT ASSETS OF BIOREFERENCE HEALTH'S DIAGNOSTICS BUSINESS FROM OPKO HEALTH Source text for Eikon: ID:nPnbrzkBja Further company coverage: LH.N

Reuters - 2 oy oldin

U.S. Constellation Energy, Eli Lilly, Talen Energy

U.S. RESEARCH ROUNDUP-Constellation Energy, Eli Lilly, Talen Energy Sept 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Constellation Energy, Eli Lilly and Talen Energy, on Friday. HIGHLIGHTS * Constellation Energy Corp CEG.O : Jefferies initiates with hold rating; target $183 * Eli Lilly LLY.N : JP Morgan raises target price to $1,100 from $1,050 * Moderna MRNA.O : JP Morgan cuts to underweight from neutral * Vo

Shartlar

Ommabop aktivlar

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.